Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sequenced Chemotherapy With Dacarbazine and Carmustine With Neulasta® Support in Previously Treated Metastatic Melanoma

NCT01692691 is registered in ClinicalTrials.gov with Western Regional Medical Center as lead sponsor.

NCT NCT01692691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01692691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sequenced Chemotherapy With Dacarbazine and Carmustine With Neulasta® Support in Previously Treated Metastatic Melanoma
Lead sponsor
Western Regional Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2012
Completion date
October 31, 2014
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma metastatic